Weight loss drugs like Ozempic were associated with a lower risk of suicidal thoughts in teens with obesity, a new study found.
Sales of GLP-1 weight-loss medications like Wegovy and Zepbound (tirzepatide) have boomed among adults, and with 1 in every 5 U.S. children now obese, the drugs' uptake by adolescents is also surging.
Amgen stock dipped Monday after an analyst downgraded shares, saying the opportunity for its weight-loss drug is already ...
Amgen has a lot riding on an experimental obesity drug that it hopes will rival those of Eli Lilly and Novo Nordisk. But one ...